2004

Applications of Pharmacokinetic Principles in Drug Development

Editors:

ISBN: 978-1-4613-4842-9 (Print) 978-1-4419-9216-1 (Online)

Table of contents (15 chapters)

  1. Front Matter

    Pages i-xvi

  2. No Access

    Book Chapter

    Pages 1-20

    Efficient and Effective Drug Development

  3. No Access

    Book Chapter

    Pages 21-52

    Bioanalytical Methods: Challenges and Opportunities in Drug Development

  4. No Access

    Book Chapter

    Pages 53-74

    Predicting Human Oral Bioavailability Using in Silico Models

  5. No Access

    Book Chapter

    Pages 75-132

    Drug Metabolism In Preclinical Development

  6. No Access

    Book Chapter

    Pages 133-175

    Interspecies Scaling

  7. No Access

    Book Chapter

    Pages 177-194

    Human Drug Absorption Studies In Early Development

  8. No Access

    Book Chapter

    Pages 195-223

    Food-Drug Interactions: Drug Development Considerations

  9. No Access

    Book Chapter

    Pages 225-243

    Global Regulatory And Biopharmaceutics Strategies In New Drug Development: Biowaivers

  10. No Access

    Book Chapter

    Pages 245-305

    Special Population Studies In Clinical Development: Pharmacokinetic Considerations

  11. No Access

    Book Chapter

    Pages 307-331

    Drug-Drug Interactions

  12. No Access

    Book Chapter

    Pages 333-372

    Pharmacokinetic/Pharmacodynamic Modeling in Drug Development

  13. No Access

    Book Chapter

    Pages 373-404

    Population Pharmacokinetic and Pharmacodynamic Modeling

  14. No Access

    Book Chapter

    Pages 405-425

    Role of Preclinical Metabolism and Pharmacokinetics in The Development of Celecoxib

  15. No Access

    Book Chapter

    Pages 427-475

    The Role of Clinical Pharmacology and of Pharmacokinetics in The Development of Alendronate - A Bone Resorption Inhibitor

  16. No Access

    Book Chapter

    Pages 477-528

    Optimizing Individualized Dosage Regimens of Potentially Toxic Drugs

  17. Back Matter

    Pages 529-550